Agios Pharmaceuticals Ownership | Who Owns Agios Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Agios Pharmaceuticals Ownership Summary

Agios Pharmaceuticals is owned by 98.38% institutional investors, 1.55% insiders, and 0.07% retail investors. Farallon capital management is the largest institutional shareholder, holding 9.95% of AGIO shares. BB Biotech AG Ord is the top mutual fund, with 6.57% of its assets in Agios Pharmaceuticals shares.

AGIO Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Agios Pharmaceuticals	98.38%	1.55%	0.07%
Sector	Healthcare Stocks	47.31%	8.01%	44.69%
Industry	Biotech Stocks	45.43%	7.81%	46.75%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Farallon capital management	5.65M	9.95%	$243.82M
Vanguard group	5.50M	9.68%	$237.02M
Blackrock	4.86M	8.55%	$209.52M
Bellevue group	3.88M	6.83%	$167.29M
Price t rowe associates inc /md/	2.78M	4.89%	$119.76M
Dimensional fund advisors lp	2.20M	3.87%	$94.70M
State street	2.11M	3.72%	$91.20M
Armistice capital	2.08M	3.66%	$89.65M
Jpmorgan chase	1.78M	3.13%	$76.59M
Macquarie group	1.73M	3.05%	$74.59M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Caligan partners lp	514.71K	5.19%	$22.19M
Bellevue group	3.88M	2.72%	$167.29M
Parkman healthcare partners	446.42K	2.58%	$19.25M
Eagle health investments lp	330.83K	2.50%	$14.27M
Sector gamma as	121.84K	1.96%	$5.25M
Frazier life sciences management	871.97K	1.76%	$37.60M
Bvf inc/il	1.19M	1.44%	$51.32M
Rock springs capital management lp	1.04M	1.36%	$45.03M
Farallon capital management	5.65M	1.15%	$243.82M
Armistice capital	2.08M	1.13%	$89.65M

Top Buyers

Holder	Shares	% Assets	Change
Bvf inc/il	1.19M	1.44%	1.19M
Marshall wace, llp	1.13M	0.07%	855.74K
Price t rowe associates inc /md/	2.78M	0.01%	764.27K
Schonfeld strategic advisors	464.12K	0.13%	464.12K
Loomis sayles & co l p	448.86K	0.03%	448.86K

Top Sellers

Holder	Shares	% Assets	Change
State street	2.11M	0.00%	-1.02M
T. rowe price investment management	-	-	-928.60K
Armistice capital	2.08M	1.13%	-884.85K
Rock springs capital management lp	1.04M	1.36%	-720.24K
Jpmorgan chase	1.78M	0.01%	-696.54K

New Positions

Holder	Shares	% Assets	Change	Value
Bvf inc/il	1.19M	1.44%	1.19M	$51.32M
Schonfeld strategic advisors	464.12K	0.13%	464.12K	$20.01M
Loomis sayles & co l p	448.86K	0.03%	448.86K	$19.36M
Parkman healthcare partners	446.42K	2.58%	446.42K	$19.25M
Candriam s.c.a.	322.88K	0.08%	322.88K	$13.92M

Sold Out

Holder	Change
Principal securities	-10.00
Nelson, van denburg & campbell wealth management group	-11.00
Covestor	-12.00
Innealta capital	-17.00
Systm wealth solutions	-35.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	218	9.00%	55,883,066	-6.01%	98	0.88%	102	-0.97%	78	39.29%
Mar 31, 2024	200	11.73%	59,453,348	2.90%	105	0.98%	103	9.57%	56	12.00%
Dec 31, 2023	179	15.48%	57,776,522	1.07%	103	0.99%	94	40.30%	50	6.38%
Sep 30, 2023	155	-4.91%	57,163,101	-0.88%	102	0.95%	67	-17.28%	47	6.82%
Jun 30, 2023	163	-6.32%	57,672,069	0.62%	103	0.96%	81	9.46%	44	-30.16%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
BB Biotech AG Ord	3.74M	6.57%	-137.63K
Vanguard Total Stock Mkt Idx Inv	1.77M	3.11%	-12.60K
iShares Russell 2000 ETF	1.45M	2.55%	-3.28K
Vanguard Small Cap Index	1.43M	2.50%	2.80K
Delaware Small Cap Core I	1.38M	2.42%	-8.55K
T. Rowe Price Health Sciences	1.32M	2.32%	-12.88K
Polar Capital Biotech S Inc	1.00M	1.75%	-
SPDR® S&P Biotech ETF	987.08K	1.73%	10.92K
Vanguard Institutional Extnd Mkt Idx Tr	850.47K	1.49%	-21.10K
Vanguard Small Cap Growth Index Inv	783.61K	1.37%	-1.75K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 08, 2024	Washburn Theodore James Jr.	Principal Accounting Officer	Sell	$43.30K
Nov 08, 2024	Ballal Rahul D.	-	Sell	$288.69K
Nov 07, 2024	Ballal Rahul D.	-	Sell	$433.60K
Nov 08, 2024	Ballal Rahul D.	-	Sell	$204.40K
Nov 08, 2024	Ballal Rahul D.	-	Sell	$88.81K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	2
2024 Q2	-	3
2024 Q1	-	31
2023 Q3	-	6
2023 Q2	-	7

AGIO Ownership FAQ

Who Owns Agios Pharmaceuticals?

Agios Pharmaceuticals shareholders are primarily institutional investors at 98.38%, followed by 1.55% insiders and 0.07% retail investors. The average institutional ownership in Agios Pharmaceuticals's industry, Biotech Stocks , is 45.43%, which Agios Pharmaceuticals exceeds.

Who owns the most shares of Agios Pharmaceuticals?

Agios Pharmaceuticals’s largest shareholders are Farallon capital management (5.65M shares, 9.95%), Vanguard group (5.5M shares, 9.68%), and Blackrock (4.86M shares, 8.55%). Together, they hold 28.19% of Agios Pharmaceuticals’s total shares outstanding.

Does Blackrock own Agios Pharmaceuticals?

Yes, BlackRock owns 8.55% of Agios Pharmaceuticals, totaling 4.86M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 209.52M$. In the last quarter, BlackRock increased its holdings by 200.91K shares, a 4.31% change.

Who is Agios Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Caligan partners lp is Agios Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 5.19% of its assets in 514.71K Agios Pharmaceuticals shares, valued at 22.19M$.

Who is the top mutual fund holder of Agios Pharmaceuticals shares?

BB Biotech AG Ord is the top mutual fund holder of Agios Pharmaceuticals shares, with 6.57% of its total shares outstanding invested in 3.74M Agios Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools